AI Chatbot Education for Improving HPV Knowledge Among University Students (AIHPV)
Effect of an AI Chatbot-Based Educational Program on HPV Knowledge Among University Students
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
Study Purpose
The purpose of this study was to evaluate the effectiveness of an AI chatbot-based educational program in improving Human Papillomavirus (HPV) knowledge among undergraduate nursing students.
Study Design
This study was designed as a parallel-group randomized controlled trial conducted among undergraduate nursing students at Cyprus International University, Northern Cyprus. Participants were randomly assigned to either the intervention group (AI chatbot-based personalized education) or the control group (standard written educational materials) using block randomization.
Sample Size
Based on a previous educational intervention study and the two-sample mean comparison formula, with a significance level of 0.05 and a statistical power of 80%, the required sample size was calculated as 30 participants per group. After allowing for a 10% dropout rate, a total of 68 participants were enrolled, with 34 participants allocated to each study group.
Data Collection Tools
Data were collected using:
A demographic questionnaire (age, gender, faculty, year of study, previous HPV education, source of HPV information, and HPV vaccination status).
The validated 29-item HPV Knowledge Questionnaire developed , assessing general HPV knowledge, HPV testing knowledge, and HPV vaccination knowledge.
Intervention
Participants were randomly assigned to one of two groups.
AI Chatbot Group:
Participants received personalized HPV education through an artificial intelligence (AI) chatbot. Educational content was tailored according to each participant's baseline HPV knowledge and included information on HPV transmission, risk factors, HPV-related diseases, vaccination, prevention strategies, and common misconceptions.
Control Group:
Participants received standard written educational materials covering the same HPV-related topics without chatbot interaction or personalized educational content.
Outcome Assessment
HPV knowledge was measured before and after the educational intervention using the validated HPV Knowledge Questionnaire.
Ethical Considerations
The study received approval from the Cyprus International University Ethics Review Board (Approval No. EKK25-26/15/08). The study was conducted in accordance with the Declaration of Helsinki, and written informed consent was obtained from all participants before enrollment.
Statistical Analysis
Data will be analyzed using SPSS version 26. Descriptive statistics, independent t-tests, paired t-tests, Chi-square tests, Fisher's exact tests, and non-parametric tests will be performed as appropriate. Statistical significance will be be set at a two-sided P value of less than 0.05.
研究の種類
研究の種類
入学 (実際)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
North Cyprus
-
Nicosia、North Cyprus、キプロス
- Pouran Varvani Farahani
-
-
参加基準
適格基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- All students, both female and male, first semester of bachelor's degree, studying in nursing department Enrollment at Cyprus International University
- Willingness to participate and provide written informed consent
- No prior formal education on HPV
Exclusion Criteria:
- Withdrawal of consent at any stage of the study
- Failure to complete either the pre-test or post-test assessments
- Incomplete participation in the educational intervention
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：防止
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的：AI Chatbot-Based Education
Participants in this group received personalized education about Human Papillomavirus (HPV) through an artificial intelligence (AI) chatbot.
The educational content was tailored according to each participant's baseline HPV knowledge and covered HPV transmission, risk factors, HPV-related diseases, HPV vaccination, prevention strategies, and common misconceptions
|
Participants received personalized education through an artificial intelligence (AI) chatbot.
Educational content was tailored according to each participant's baseline HPV knowledge and included information on HPV transmission, risk factors, HPV-related diseases, HPV vaccination, prevention strategies, and common misconceptions.
The chatbot provided interactive, personalized educational support throughout the intervention
|
|
アクティブコンパレータ：Standard Written Education
Participants in this group received standard written educational materials covering the same HPV-related topics, including HPV transmission, risk factors, HPV-related diseases, HPV vaccination, and prevention strategies.
No personalized feedback or AI chatbot interaction was provided
|
Participants received standard written educational materials covering HPV transmission, risk factors, HPV-related diseases, HPV vaccination, and prevention strategies.
The educational materials were identical in content to the intervention group but were provided without personalization or AI chatbot interaction
|
この研究は何を測定していますか？
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
HPV Knowledge Score
時間枠：Baseline (before the educational intervention) and 1 month after completion of the educational intervention.
|
The primary outcome measure assesses changes in participants' knowledge of Human Papillomavirus (HPV) following the educational intervention.
HPV knowledge is measured using the validated 29-item HPV Knowledge Questionnaire developed by Waller et al. (2013).
The questionnaire evaluates three domains: general HPV knowledge, HPV testing knowledge, and HPV vaccination knowledge.
Higher total scores indicate greater HPV-related knowledge
|
Baseline (before the educational intervention) and 1 month after completion of the educational intervention.
|
協力者と研究者
捜査官
捜査官
- 主任研究者：Pouran Varvani Farahani, PhD、PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- PVF-HPV-AI-2026
- EKK25-26/15/08 (その他の識別子：Cyprus International University Ethics Review Board)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。